As healthcare costs continue to rise at the steepest rate in more than a decade, employers are being forced to rethink how benefits strategies are evaluated, defended, and sustained. In this environment, women’s health has emerged as a critical employee priority and a significant financial lever, influencing maternity costs, chronic conditions, productivity, retention, and long-term medical spend.
In the past, many benefits strategies were built primarily for access and retention. Planning for 2027 will require a sharper focus on performance.
From access to accountability
Women’s health is multifaceted, spanning reproductive years, family building, maternity, menopause, chronic conditions, and preventive care. Too often, employers address this complexity by layering solutions, which expands access without improving coordination, outcomes, or cost control.
This results in a fragmented ecosystem that increases administrative burden, obscures ROI, and allows risk to accumulate quietly rather than appear as an immediate crisis.
For 2027, the question is no longer: “What do we offer?” It is: “What does this deliver (clinically, operationally, and financially)?”
Why performance must be measurable to be defensible
In a budget-constrained environment, benefits decisions must be able to withstand review from finance leaders, consultants, and executive teams. Programs that rely only on engagement metrics or self-reported satisfaction are difficult to justify.
Strong women’s health strategies leave visible signals:
- Clear attribution of cost containment and avoided high-cost claims
- Measurable improvements in clinical outcomes and risk mitigation
- Simplified operational processes
- Accountable and transparent reporting that supports forecasting and long-term planning
These signals distinguish programs that actively manage cost and risk.
Where cost containment and high member value meet
The greatest opportunities for value in women’s health are in areas that influence the severity, duration, and downstream cost of care. Fertility, maternity, and menopause consistently represent outsized financial exposure when left unmanaged or fragmented across vendors.
Solutions that deliver high quality, equitable care across life stages while coordinating navigation, clinical oversight, and reporting are better positioned to reduce quiet inefficiencies that compound over time.
A framework for asking better questions in 2027 planning
To help employers and consultants navigate this shift, Progyny has developed a strategic planning guide that outlines 10 essential questions to ask during benefits planning sessions, along with guidance on what strong answers should include.
Rather than focusing on features or access alone, the framework is designed to help organizations evaluate:
- Where the largest cost and risk drivers truly sit
- How outcomes and ROI are measured and attributed
- Whether vendor sprawl is diluting performance
- How care is delivered, coordinated, and supported at scale
- What signals indicate readiness for sustainable cost control
This guide supports disciplined, defensible decision-making and will help organizations pressure-test whether their current strategy is built for the realities of 2027.
The strongest benefits strategies are not defined by the number of programs offered. They are defined by how clearly performance, outcomes, and financial impact can be measured, managed, and sustained over time.
As employers prepare for 2027, asking better questions is the first step toward building a women’s health strategy that delivers both measurable ROI and meaningful employee impact.
Sign up to get the guide
Download Progyny’s guide, Strategic questions for 2027 benefits planning: Driving value amid rising healthcare costs, and use it to support your next planning conversation.